PRMT5 and neoplasm: Similarly, ADC tumor samples exhibited a 1.94-fold decrease (p = 0.0145), indicating a consistent downregulation of pRb expression in tumors, likely reflecting the downstream impact of the dysregulated PPM1B/MP/PRMT5/H2A pathway.